Coronary Artery Disease Clinical Trial
Official title:
A Randomized Controlled Trial in Women With Coronary Artery Disease Investigating the Effects of Aerobic Interval Training Versus Moderate Intensity Continuous Exercise in the Standard Cardiac Rehabilitation Setting: Aerobic Exercise Capacity and Cognitive Function
Heart disease is the number one killer amongst chronic diseases around the world, and it is responsible for taking the lives of an estimated 17.5 million people each year. Exercise-based cardiac rehabilitation (CR) programs, which help heart patients improve their current health, prevent future heart problems, and improve their quality of life, are an effective strategy for lowering the risk of heart-related deaths in heart patients. CR programs currently have their patients perform moderate intensity, continuous exercise (MICE), which traditionally takes the form of walking, jogging, or cycling at a comfortable pace for 30-60 minutes. Recently, aerobic interval training (AIT), which involves performing short bouts of exercise, typically ranging from 15 seconds to four minutes at near maximal effort, followed by periods of recovery or rest, has emerged as a more effective strategy than MICE for lowering the risk of heart-related deaths in heart patients. Although these initial findings appear to hold much promise for improving CR programs in the future, it is important to recognize that women have been underrepresented or not included in these studies to date. Therefore, the goal of this study is to determine the effects of AIT versus MICE on the risk of heart-related death, blood vessel health, and brain health in women who have heart disease, and who have been referred to a six-month, outpatient CR program.
This will be the first randomized controlled trial (RCT) investigating the effects of AIT
versus MICE on aerobic exercise capacity, endothelial function, and cognition, in women only,
who have CAD and have been referred to the six-month, outpatient CR program at the Toronto
Rehabilitation Institute (TRI)-Cardiac Rumsey Centre. Study participants will be reporting to
the Rumsey Centre one day per week for a combination of supervised exercise sessions and
educational seminars or workshops, and they will be performing four additional unsupervised,
home-exercise sessions per week for a target total of five exercise sessions per week.
Recruitment and Sampling
Immediately after completion of a symptom-limited intake CPA, a previously identified
eligible patient who would have been screened for eligibility upon her referral to the
six-month, outpatient CR program at the TRI-Cardiac Rumsey Centre will be asked by either the
Cardiopulmonary Exercise Technicians, or Lab Coordinator performing the initial CPA, if she
would be interested in speaking to a researcher and learning more about potential
participation in this research study. If the patient agrees to speak to the researcher, the
researcher will meet the patient in person immediately following the CPA to explain the study
and to obtain voluntary, written and informed consent if applicable. Patients will be
provided with the opportunity to take the consent forms home, and to discuss participation in
the study with their spouses or other family members, etc., and to take as much time is
required to decide whether participation in the study is a desirable option for them.
If, and when a patient provides written and informed consent to participate in the study, she
will be randomized by a computerized random number generator (operated by a blinded third
party researcher) to either the six-month standard of care CR program offered at the
TRI-Rumsey Centre involving MICE, or to the 6-month AIT intervention. Both the MICE and AIT
arms of the study will consist of patients attending one, supervised exercise session per
week at the TRI-Rumsey Centre, and they will perform four additional unsupervised
home-exercise sessions per week for a total of five exercise sessions per week as the goal.
The AIT Intervention
The AIT Group will begin with a one-month, "run-in" period where patients will perform
current standard of care CR programming, which will involve traditional MICE. MICE at the
Cardiac Rumsey Centre will consist of either track walking/jogging or treadmill
walking/jogging for approximately 30-40 minutes, performed at an intensity of 60-80% of
VO2peak, in addition to a warm-up and cool down period. In the second month of the study
intervention, patients will begin to perform AIT three days per week, with one of those AIT
exercise sessions occurring at the Rumsey Centre under supervision, and 2 sessions per week
of MICE, which will again consist of the 30-40 minutes of walking/jogging at an intensity of
60-80% of VO2peak, with an allotted warm up and cool down period.
The AIT Exercise Protocol
Upon examination of the most recent RCTs investigating AIT versus MICE between 2004 and 2016,
specifically in the CAD population, the AIT intervention group experienced greater
improvements in VO2peak, which translated to ~1.5-2 mL kg-1 min-1 improvements compared to
the MICE (control) group. These results are compelling, particularly in the context of a
potential 10-25% reduction in cardiovascular mortality risk above and beyond what would have
been conferred by standard of care MICE prescription. In almost 90% of these most recent RCTs
comparing the effects of AIT versus MICE on aerobic exercise capacity in CAD patients, the
AIT exercise protocol consisted of 4x4 minute intervals of treadmill walking at either 80-90%
of VO2peak, or 85-95% of HRpeak, or 80-90% of Heart Rate Reserve (HRR=HRpeak-resting HR),
with 3 minutes of active recovery between the 4-minute intervals, performed at an intensity
of ~50-70% of VO2peak, HRpeak, or HRR.
Therefore, in remaining consistent with the previous literature supporting AIT in CAD
patients, the AIT exercise protocol that the participants will be executing in this study
consists of the following components:
1. Warm Up Period: 5-10 minutes of walking performed at 50%-60% of VO2peak and/or the
corresponding HR (~60%-70% HRpk) and/or RPE of ~10-12 on the Borg Scale
2. Intervals: Four 4-minute intervals of walking/jogging performed at an intensity of
85-95% of VO2peak, or >90% of HRpk, and/or RPE >17 on the Borg Scale, interspersed with
3-minutes of active recovery performed at an intensity of ~50%-70% HRpk
3. Cool Down Period: 5 minutes of walking performed at an intensity of 50-70% HRpk, and/or
RPE ~10-12 on the Borg Scale Understanding that we must be cognizant of the fact that
each study participant may respond and progress to this AIT intervention at different
rates, it is our intention to begin with two 4-minute intervals in the first week of the
AIT intervention, and then to progress participants to performing three, and then
eventually four 4-minute intervals by the fourth week of the intervention, i.e. the end
of Month 2 in the study/CR program timeline. The decision to progress patients
accordingly will be made judiciously upon deliberation of both researcher and cardiac
rehabilitation supervisor/case manager for each study participant.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |